| Literature DB >> 32634451 |
Timothy Cr Prickett1, Eric A Espiner2.
Abstract
Paracrine actions of CNP and rapid degradation at source severely limit study of CNP's many roles in vivo. However provided sensitive and validated assays are used, there is increasing evidence that low concentrations of bioactive CNP in plasma, and the readily detectable concentrations of the bio-inactive processed product of proCNP (aminoterminal proCNP), can be used to advance understanding of the hormone's role in pathophysiology. Provided renal function is normal, concordant changes in both CNP and NTproCNP reflect change in tissue production of proCNP whereas change in CNP alone results from altered rates of bioactive CNP degradation and are reflected in the ratio of NTproCNP to CNP. As already shown in juveniles, where plasma concentration of CNP products are higher and are associated with concurrent endochondral bone growth, measurements of plasma CNP products in mature adults have potential to clarify organ response to stress and injury. Excepting the role of CNP in fetal-maternal welfare, this review examines evidence linking plasma CNP products with function of a wide range of tissues in adults, including the impact of extraneous factors such as nutrients, hormone therapy and exercise.Entities:
Keywords: BNP; Bone turnover markers; Myocardial fibrosis; NTproCNP; Osteocrin; Vascular risk factors
Mesh:
Substances:
Year: 2020 PMID: 32634451 DOI: 10.1016/j.peptides.2020.170363
Source DB: PubMed Journal: Peptides ISSN: 0196-9781 Impact factor: 3.750